PORT WASHINGTON – Pall Corporation, a leader in filtration, separation, and purification, is hiring 300 people to staff its new 220,000-square-foot manufacturing facility in Duncan in Spartanburg County, South Carolina.
The newly opened site will make mostly single-use bioprocessing equipment.
In July 2021, Pall and Cytiva, companies within the New York-headquartered Danaher Corporation, announced they are investing $1.5 billion over two years to expand their operations to meet both short term demand as well as long term projected growth.
Products made at the Spartanburg site, including those from the Allegro platform, are used in all the essential manufacturing steps – including creation, purification and packaging – for biotechnology and pharmaceutical products such as antibiotics, antibodies, and vaccines, including Covid-19 vaccines.
“We’re excited to join the Duncan community and welcome new associates to our growing team,” said Pall president Joseph Repp. “Pall has a proud 75-year history of supporting development of life-saving vaccines and therapeutics. The important products we make here in South Carolina are used by customers around the world and critical to Pall’s global expansion plans as we increase production globally.”
To meet ambitious expansion plans, Pall’s hiring process has been accelerated and further roles are expected to be announced in 2022. New associates in Duncan are joining from a variety of career backgrounds and receive onboarding training at a local community college.
